Xponance Inc. Has $6.96 Million Holdings in Aflac Incorporated (NYSE:AFL)

Xponance Inc. lessened its holdings in Aflac Incorporated (NYSE:AFL) by 4.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 77,909 shares of the financial services provider’s stock after selling 3,575 shares during the period. Xponance Inc.’s holdings in Aflac were worth $6,958,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the stock. Clearbridge Investments LLC acquired a new stake in Aflac during the fourth quarter worth about $484,000. Cambridge Investment Research Advisors Inc. lifted its position in shares of Aflac by 13.9% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 100,019 shares of the financial services provider’s stock worth $8,252,000 after purchasing an additional 12,190 shares in the last quarter. SageView Advisory Group LLC bought a new stake in shares of Aflac during the 4th quarter valued at $253,000. Congress Wealth Management LLC DE boosted its holdings in shares of Aflac by 13.4% in the fourth quarter. Congress Wealth Management LLC DE now owns 3,040 shares of the financial services provider’s stock valued at $251,000 after buying an additional 360 shares during the period. Finally, Hilltop Holdings Inc. acquired a new stake in shares of Aflac during the fourth quarter worth $469,000. 67.44% of the stock is owned by institutional investors.

Insider Transactions at Aflac

In other news, Director Thomas J. Kenny sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total value of $197,880.00. Following the transaction, the director now owns 18,158 shares in the company, valued at approximately $1,796,552.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.90% of the company’s stock.

Aflac Trading Up 1.9 %

AFL opened at $110.00 on Tuesday. The company’s 50 day moving average is $103.21 and its 200-day moving average is $92.22. The company has a market cap of $62.50 billion, a P/E ratio of 12.14, a PEG ratio of 2.53 and a beta of 0.95. Aflac Incorporated has a 1-year low of $74.89 and a 1-year high of $111.14. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.23. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $4.10 billion. During the same quarter in the previous year, the company posted $1.58 EPS. The business’s revenue was down .7% on a year-over-year basis. Equities research analysts predict that Aflac Incorporated will post 6.75 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were paid a $0.50 dividend. The ex-dividend date was Wednesday, August 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.82%. Aflac’s payout ratio is presently 22.08%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Barclays initiated coverage on Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 target price for the company. Piper Sandler lifted their price objective on shares of Aflac from $95.00 to $100.00 and gave the stock an “overweight” rating in a research report on Friday, June 28th. Morgan Stanley increased their price objective on shares of Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research report on Monday, August 19th. JPMorgan Chase & Co. lifted their target price on shares of Aflac from $80.00 to $83.00 and gave the stock a “neutral” rating in a report on Tuesday, July 2nd. Finally, Bank of America increased their price target on shares of Aflac from $108.00 to $115.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Aflac presently has a consensus rating of “Hold” and a consensus target price of $92.50.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.